Bacac M - Search Results

1

New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.

Hotze AC, Bacac M, Velders AH, Jansen BA, Kooijman H, Spek AL, Haasnoot JG, Reedijk J. Hotze AC, et al. Among authors: bacac m. J Med Chem. 2003 Apr 24;46(9):1743-50. doi: 10.1021/jm021110e. J Med Chem. 2003. PMID: 12699392

2

The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation.

Bacac M, Hotze AC, van der Schilden K, Haasnoot JG, Pacor S, Alessio E, Sava G, Reedijk J. Bacac M, et al. J Inorg Biochem. 2004 Feb;98(2):402-12. doi: 10.1016/j.jinorgbio.2003.12.003. J Inorg Biochem. 2004. PMID: 14729322

3

Structure-dependent in vitro cytotoxicity of the isomeric complexes [Ru(L)2Cl2] (L= o-tolylazopyridine and 4-methyl-2-phenylazopyridine) in comparison to [Ru(azpy)2Cl2].

Hotze AC, Caspers SE, de Vos D, Kooijman H, Spek AL, Flamigni A, Bacac M, Sava G, Haasnoot JG, Reedijk J. Hotze AC, et al. Among authors: bacac m. J Biol Inorg Chem. 2004 Apr;9(3):354-64. doi: 10.1007/s00775-004-0531-6. Epub 2004 Mar 19. J Biol Inorg Chem. 2004. PMID: 15034769

4

Automated parallel solid-phase synthesis and anticancer screening of a library of peptide-tethered platinum(II) complexes.

Robillard MS, Bacac M, van den Elst H, Flamigni A, van der Marel GA, van Boom JH, Reedijk J. Robillard MS, et al. Among authors: bacac m. J Comb Chem. 2003 Nov-Dec;5(6):821-5. doi: 10.1021/cc030011z. J Comb Chem. 2003. PMID: 14606811

5

Cocultures of metastatic and host immune cells: selective effects of NAMI-A for tumor cells.

Bacac M, Vadori M, Sava G, Pacor S. Bacac M, et al. Cancer Immunol Immunother. 2004 Dec;53(12):1101-10. doi: 10.1007/s00262-004-0566-0. Cancer Immunol Immunother. 2004. PMID: 15221285 Free PMC article.

6

Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment.

Pacor S, Zorzet S, Cocchietto M, Bacac M, Vadori M, Turrin C, Gava B, Castellarin A, Sava G. Pacor S, et al. Among authors: bacac m. J Pharmacol Exp Ther. 2004 Aug;310(2):737-44. doi: 10.1124/jpet.104.066175. Epub 2004 Apr 9. J Pharmacol Exp Ther. 2004. PMID: 15075381

7

Isolation of a murine metastatic cell line and preliminary test of sensitivity to the anti-metastasis agent NAMI-A.

Pacor S, Vadori M, Vita F, Bacac M, Soranzo MR, Zabucchi G, Sava G. Pacor S, et al. Among authors: bacac m. Anticancer Res. 2001 Jul-Aug;21(4A):2523-30. Anticancer Res. 2001. PMID: 11724317

8

Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: implications for systemic use.

Pacor S, Giangaspero A, Bacac M, Sava G, Tossi A. Pacor S, et al. Among authors: bacac m. J Antimicrob Chemother. 2002 Sep;50(3):339-48. doi: 10.1093/jac/dkf141. J Antimicrob Chemother. 2002. PMID: 12205058

9

A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents.

Herter S, Morra L, Schlenker R, Sulcova J, Fahrni L, Waldhauer I, Lehmann S, Reisländer T, Agarkova I, Kelm JM, Klein C, Umana P, Bacac M. Herter S, et al. Among authors: bacac m. Cancer Immunol Immunother. 2017 Jan;66(1):129-140. doi: 10.1007/s00262-016-1927-1. Epub 2016 Nov 17. Cancer Immunol Immunother. 2017. PMID: 27858101 Free PMC article.

10

Metastatic cancer cell.

Bacac M, Stamenkovic I. Bacac M, et al. Annu Rev Pathol. 2008;3:221-47. doi: 10.1146/annurev.pathmechdis.3.121806.151523. Annu Rev Pathol. 2008. PMID: 18233952 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters